HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amal Kamal Abdel-Aziz Selected Research

Radiation-Protective Agents (Radiation Protectants)

12/2020Novel molecular mechanisms underlying the ameliorative effect of N-acetyl-L-cysteine against ϒ-radiation-induced premature ovarian failure in rats.
1/2019Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation-induced premature ovarian failure: Emphasis on TGF-β/MAPKs signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amal Kamal Abdel-Aziz Research Topics

Disease

11Neoplasms (Cancer)
01/2022 - 06/2014
3Carcinoma (Carcinomatosis)
01/2022 - 06/2014
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2020
3Breast Neoplasms (Breast Cancer)
01/2022 - 11/2019
3Chemotherapy-Related Cognitive Impairment
01/2019 - 01/2016
3Cognitive Dysfunction
01/2019 - 01/2016
2Ascites
01/2022 - 06/2014
2Leukemia
01/2022 - 01/2020
2Primary Ovarian Insufficiency
12/2020 - 01/2019
2Carcinogenesis
12/2014 - 06/2014
1Colonic Neoplasms (Colon Cancer)
01/2022
1Acute Promyelocytic Leukemia
01/2022
1Necrosis
12/2021
1COVID-19
01/2021
1Triple Negative Breast Neoplasms
11/2019
1Infertility (Sterility)
01/2019
1Arthritis (Polyarthritis)
10/2018
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2017
1Renal Cell Carcinoma (Grawitz Tumor)
01/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2015
1Melanoma (Melanoma, Malignant)
12/2014

Drug/Important Bio-Agent (IBA)

4Sunitinib (Sutent)FDA Link
01/2017 - 06/2014
3Phosphotransferases (Kinase)IBA
01/2017 - 06/2014
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2017
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 01/2019
2Radiation-Protective Agents (Radiation Protectants)IBA
12/2020 - 01/2019
2Mechanistic Target of Rapamycin Complex 1IBA
01/2020 - 01/2017
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 07/2018
2Imatinib Mesylate (Gleevec)FDA Link
01/2017 - 01/2015
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2016 - 01/2016
2Tyrosine Kinase InhibitorsIBA
01/2016 - 06/2014
1EnzymesIBA
01/2022
1fms-Like Tyrosine Kinase 3IBA
01/2022
1benzimidazoleIBA
01/2022
1Histone Deacetylases (Histone Deacetylase)IBA
01/2022
1CholesterolIBA
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2022
1FluvastatinFDA Link
01/2022
1Aurora Kinase BIBA
12/2021
1indolin-2-oneIBA
12/2021
1Histones (Histone)IBA
12/2021
1VaccinesIBA
01/2021
1Acetylcysteine (Siran)FDA LinkGeneric
12/2020
1Lysine (L-Lysine)FDA Link
01/2020
1atezolizumabIBA
11/2019
1130-nm albumin-bound paclitaxelIBA
11/2019
1Immune Checkpoint InhibitorsIBA
11/2019
1AlbuminsIBA
11/2019
1LigandsIBA
11/2019
1chrysinIBA
01/2019
1Ranibizumab (Lucentis)FDA Link
10/2018
1Monoclonal AntibodiesIBA
10/2018
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
10/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018
1tocilizumab (atlizumab)FDA Link
10/2018
1Lapatinib (GW572016)FDA Link
07/2018
1AntioxidantsIBA
07/2018
1astaxanthine (astaxanthin)IBA
07/2018
1Selenious Acid (Selenite)IBA
01/2015
1Beclin-1IBA
12/2014
1Tyrosine (L-Tyrosine)FDA Link
06/2014
1Chloroquine (Aralen)FDA LinkGeneric
06/2014
1Antimalarials (Antimalarial Agents)IBA
06/2014
1Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2014

Therapy/Procedure

4Therapeutics
12/2021 - 06/2014
2Radiotherapy
12/2020 - 01/2019
2Drug Therapy (Chemotherapy)
01/2019 - 01/2016
1Immunotherapy
01/2021